Efficacy and safety of the activin signalling inhibitor sotatercept

As part of its May issue, the European Respiratory Journal presents the latest in its series of podcasts. In this episode, Chief Editor James Chalmers interviews Associate Editor Marius Hoeper about the efficacy and safety of the activin signalling inhibitor sotatercept in a pooled analysis of PULSAR and STELLAR studies.

 

 

Download the podcast

Listen on Soundcloud

Listen on Spotify

Listen on Apple Podcasts

Recent episodes

Watch previous episodes

Load more